Innovation for Health - 13 February 2020
Contact Global Investor Forum I4H Bootcamp
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Ton Rijnders

Scientific Director, Lygature & The European Lead Factory & General Director, Oncode Institute

Ton Rijnders holds a PhD in molecular biology. He joined the Dutch pharmaceutical company Organon in 1986 and moved to the position of Vice President Research in 2003. After the acquisition of Organon by Schering-Plough in 2007, Ton was appointed VP Discovery and Site Head Oss and continued this position after the merger of Merck and Schering-Plough. In 2011 Ton co-founded TI Pharma, a public private partnership in drug discovery, and acted as its Scientific Director. He continued this work after the merger of CTMM and TI Pharma into Lygature in 2016.

Ton currently holds the position of General Director at Oncode Institute. By combining individual excellence and collaborative development, Oncode works towards innovative cancer treatments. He uses his experience to bring together the great minds of cancer research in The Netherlands.

Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.